OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/07/2026
Voltar para busca
Dado oficial do USPTO
2BIND
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
16/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 42
Data de depósito
12/04/2024
Data de registro
11/11/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/11/2025
Última transação
16/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
27
Localização do titular
Regensburg, DE
Examinador
HUDSON, TAMARA BREE
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of "2BIND" in stylized font wherein the number "2" is in red and the word "BIND" is in blue and partially intermingled with the number "2".
Titulares e representantes
Titulares
2bind GmbH
Representantes
Miriam D. Trudell Davis Graham & Stubbs LLP
Classificação técnica
Classes Nice
Classe 1Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for scientificresearchlaboratoryindustrial and commercial purposes ‘other than for medical and veterinary purposes; chemicalbiochemical and biological preparations for use in biophysical and biotechnological process for scientificresearchlaboratoryindustrial and commercial purposes; diagnostic reagentsbuffersbuffer solutionsbuffer-screening stock solutionsbioliquidsligandsHIV-immunogensantibodiesin particular therapeutic antibodiesmonoclonal antibodiesantibody reagentsproteinsaptamersantigensbiochemicals for in vitro and in vivo applications for scientificresearchlaboratoryindustrial and commercial purposesall the aforesaid except for medical and veterinary purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for the developmentmanufacture and research in the fields of biologybiotechnologybiochemistrychemistrypharmacy and cosmetics‘ other than for medical and veterinary purposes; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for scientific and medical research and for scientific research and development in the field of medicine; chemicalbiochemical and biological preparations for the research and development of biophysical and biotechnological products; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for the manufacture of medicine and pharmaceutical preparations; chemicalbiochemical and biological preparations for the manufacture of biophysical and biotechnological products; chemicals and chemical agentscompoundspreparationsreagents and substances for laboratory analysisin particular bacterial preparations and bacteriological preparationsexcept for medical and veterinary purposes
Classe 42
Scientific research servicesconducting of biophysical interactions analyses for determining binding parameters of molecular interactions; scientific laboratory servicesplasmid cloningprotein expression in e.coliprotein purification and fluorescent protein marking; science and technology research services; research and development services in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industry and cosmetology; medical and pharmaceutical research and development; scientifictechnological and industrial analysis and research in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; scientific laboratory services; research laboratory services; analytical laboratory services; laboratory testing services for scientific research; scientific research in the nature of conducting of scientific experiments and tests; consultancy in the field of scientificindustrial and technological research and development; providing of information relating to industrial and scientific analysisresearch and development in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; providing of information relating to technological research and development in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; industrial development services in the fields of engineeringbiophysicsbioinformaticspharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; conducting scientific studies for others in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; development of industrial processes for others; development of new products for others; development of new technology for others; development and testing of chemicalbiochemical and biological manufacturing processes; research and development in the nature of developing testing methods and research and development services for developing methods of testing; development of machining techniques; research and development relating to medicinespharmaceuticalsmedical goodsdiagnosticsdiagnostic and analysis goodsfoodcosmeticscleaning preparations and disinfectants; research and development services and industrialscientific and technological laboratory services relating to protein and RNA-based medicine developmentantibody developmentprotein analysisaptamer development and the determination of molecular interactions
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/06/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/06/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/05/2026
FIMP
FINAL DISPOSITION PROCESSED
25/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/02/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
ATRV
ATTORNEY REVIEW COMPLETED
29/09/2025
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
29/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/09/2025
PUBO
PUBLISHED FOR OPPOSITION
23/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/08/2025
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
23/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/08/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/03/2025
GNFR
FINAL REFUSAL E-MAILED
28/03/2025
CNFR
FINAL REFUSAL WRITTEN
28/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/03/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
31/01/2025
RFNT
REFUSAL PROCESSED BY IB
30/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/11/2024
RFRR
REFUSAL PROCESSED BY MPU
11/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/11/2024
CNRT
NON-FINAL ACTION WRITTEN
01/11/2024
DOCK
ASSIGNED TO EXAMINER
25/10/2024
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
20/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/07/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 2BIND ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.